Genital Diseases, Female  >>  MEDI-3617  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MEDI-3617 / AstraZeneca
NCT01248949: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Checkmark Of P1 trial for solid tumours and ovarian cancer
Feb 2017 - Feb 2017: Of P1 trial for solid tumours and ovarian cancer
Completed
1
162
US
MEDI3617, Bevacizumab, Paclitaxel, Carboplatin
MedImmune LLC
Advanced Solid Tumors, Advanced Recurrent Ovarian Tumors
07/15
10/15

Download Options